{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Meningitis%2C+Meningococcal", "query": { "condition": "Meningitis, Meningococcal" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 65, "total_pages": 7, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Meningitis%2C+Meningococcal&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-05-22T09:05:02.502Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01239043", "title": "Antibody Persistence and Response to Re-vaccination With Either Menactra® or Menomune® 3 Years After Initial Vaccination", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Meningitis", "Meningococcal Meningitis", "Meningococcal Infections" ], "interventions": [ { "name": "Menomune®: A, C, Y, W 135 Meningococcal Polysaccharide", "type": "BIOLOGICAL" }, { "name": "Menactra®: Meningococcal (A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugate", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "56 Years", "maximum_age": null, "sex": "ALL", "summary": "56 Years and older" }, "enrollment_count": 139, "start_date": "2010-11", "completion_date": "2012-02", "has_results": true, "last_update_posted_date": "2012-06-25", "last_synced_at": "2026-05-22T09:05:02.502Z", "location_count": 6, "location_summary": "Scottsdale, Arizona • Bardstown, Kentucky • Albuquerque, New Mexico + 3 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Bardstown", "state": "Kentucky" }, { "city": "Albuquerque", "state": "New Mexico" }, { "city": "West Jordan", "state": "Utah" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT01239043" }, { "nct_id": "NCT03077438", "title": "Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Meningitis", "Meningococcal Meningitis", "Meningococcal Infections" ], "interventions": [ { "name": "Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate", "type": "BIOLOGICAL" }, { "name": "Meningococcal (Groups A, C, Y and W 135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "2 Years", "maximum_age": "9 Years", "sex": "ALL", "summary": "2 Years to 9 Years" }, "enrollment_count": 1000, "start_date": "2017-02-17", "completion_date": "2017-10-10", "has_results": true, "last_update_posted_date": "2022-03-28", "last_synced_at": "2026-05-22T09:05:02.502Z", "location_count": 35, "location_summary": "Birmingham, Alabama • Dothan, Alabama • Tucson, Arizona + 31 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03077438" }, { "nct_id": "NCT00862277", "title": "Persistence of Bactericidal Antibodies in Adolescents and Adults Who Had Received a Single Dose of Menactra® Vaccine", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Meningococcal Infections", "Meningitis" ], "interventions": [ { "name": "Menactra®", "type": "BIOLOGICAL" }, { "name": "Menomune®", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "14 Years", "maximum_age": "27 Years", "sex": "ALL", "summary": "14 Years to 27 Years" }, "enrollment_count": 763, "start_date": "2008-12", "completion_date": "2009-12", "has_results": true, "last_update_posted_date": "2016-04-14", "last_synced_at": "2026-05-22T09:05:02.502Z", "location_count": 20, "location_summary": "Little Rock, Arkansas • Fountain Valley, California • Marietta, Georgia + 15 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Marietta", "state": "Georgia" }, { "city": "Martinez", "state": "Georgia" }, { "city": "Woodstock", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00862277" }, { "nct_id": "NCT00777790", "title": "Study of a Booster Dose of Meningococcal Diphtheria Toxoid Conjugate Vaccine in Adolescents", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Meningitis", "Meningococcemia" ], "interventions": [ { "name": "Meningococcal Polysaccharide Diphtheria Toxoid Conjugate", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "13 Years", "maximum_age": "21 Years", "sex": "ALL", "summary": "13 Years to 21 Years" }, "enrollment_count": 241, "start_date": "2004-02", "completion_date": "2005-04", "has_results": true, "last_update_posted_date": "2014-02-14", "last_synced_at": "2026-05-22T09:05:02.502Z", "location_count": 9, "location_summary": "Atlanta, Georgia • Marietta, Georgia • Woburn, Massachusetts + 6 more", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Marietta", "state": "Georgia" }, { "city": "Woburn", "state": "Massachusetts" }, { "city": "Albany", "state": "New York" }, { "city": "Akron", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00777790" }, { "nct_id": "NCT00718666", "title": "The Long-term Antibody Persistence of GSK Biologicals' Meningococcal Vaccine GSK134612 in Healthy Toddlers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Infections, Meningococcal" ], "interventions": [ { "name": "Meningococcal vaccine GSK134612", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "2 Years", "maximum_age": "6 Years", "sex": "ALL", "summary": "2 Years to 6 Years" }, "enrollment_count": 387, "start_date": "2008-10-20", "completion_date": "2014-03-28", "has_results": true, "last_update_posted_date": "2019-06-26", "last_synced_at": "2026-05-22T09:05:02.502Z", "location_count": 14, "location_summary": "Benton, Arkansas • Little Rock, Arkansas • Antioch, California + 10 more", "locations": [ { "city": "Benton", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Antioch", "state": "California" }, { "city": "Fremont", "state": "California" }, { "city": "Hayward", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00718666" }, { "nct_id": "NCT01461993", "title": "A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Vaccines", "Meningococcal Vaccines" ], "interventions": [ { "name": "rLP2086 and Gardasil", "type": "BIOLOGICAL" }, { "name": "rLP2086", "type": "BIOLOGICAL" }, { "name": "Gardasil", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "11 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "11 Years to 17 Years" }, "enrollment_count": 2499, "start_date": "2011-09-28", "completion_date": "2013-07-06", "has_results": true, "last_update_posted_date": "2018-12-19", "last_synced_at": "2026-05-22T09:05:02.502Z", "location_count": 87, "location_summary": "Daphne, Alabama • Chandler, Arizona • Jonesboro, Arkansas + 57 more", "locations": [ { "city": "Daphne", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Cypress", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01461993" }, { "nct_id": "NCT01897402", "title": "Immunogenicity and Safety of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Meningococcal Meningitis", "Meningococcal Infections" ], "interventions": [ { "name": "Test Vaccine", "type": "BIOLOGICAL" }, { "name": "US Licensed Vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "JN-International Medical Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 525, "start_date": "2013-07", "completion_date": "2014-12", "has_results": true, "last_update_posted_date": "2015-04-23", "last_synced_at": "2026-05-22T09:05:02.502Z", "location_count": 3, "location_summary": "Greenbelt, Maryland • Pasadena, Maryland • Towson, Maryland", "locations": [ { "city": "Greenbelt", "state": "Maryland" }, { "city": "Pasadena", "state": "Maryland" }, { "city": "Towson", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01897402" }, { "nct_id": "NCT04707391", "title": "Immunogenicity and Safety Study of GSK's MenABCWY Vaccine in Healthy Adolescents and Adults Previously Primed With MenACWY Vaccine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Meningitis, Meningococcal" ], "interventions": [ { "name": "MenABCWY vaccine", "type": "COMBINATION_PRODUCT" }, { "name": "Placebo", "type": "COMBINATION_PRODUCT" }, { "name": "MenACWY vaccine", "type": "BIOLOGICAL" }, { "name": "MenB vaccine", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT", "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "15 Years", "maximum_age": "25 Years", "sex": "ALL", "summary": "15 Years to 25 Years" }, "enrollment_count": 1250, "start_date": "2021-01-25", "completion_date": "2023-09-29", "has_results": true, "last_update_posted_date": "2024-07-03", "last_synced_at": "2026-05-22T09:05:02.502Z", "location_count": 48, "location_summary": "Jonesboro, Arkansas • Banning, California • Chula Vista, California + 42 more", "locations": [ { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Banning", "state": "California" }, { "city": "Chula Vista", "state": "California" }, { "city": "West Covina", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04707391" }, { "nct_id": "NCT00254995", "title": "Descriptive, Post-marketing, Surveillance Safety Study of Menactra Vaccine", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Meningitis", "Meningococcal Disease" ], "interventions": [ { "name": "None administered in this study", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 62626, "start_date": "2005-07", "completion_date": "2013-05", "has_results": true, "last_update_posted_date": "2016-04-19", "last_synced_at": "2026-05-22T09:05:02.502Z", "location_count": 1, "location_summary": "Oakland, California", "locations": [ { "city": "Oakland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00254995" }, { "nct_id": "NCT03621670", "title": "Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Infections, Meningococcal" ], "interventions": [ { "name": "Bexsero (GSK Biologicals' Meningococcal group-B vaccine/ rMenB+OMV NZ)", "type": "BIOLOGICAL" }, { "name": "Prevnar13", "type": "BIOLOGICAL" }, { "name": "Pediarix", "type": "BIOLOGICAL" }, { "name": "Hiberix", "type": "BIOLOGICAL" }, { "name": "Rotarix", "type": "BIOLOGICAL" }, { "name": "M-M-R II", "type": "BIOLOGICAL" }, { "name": "Varivax", "type": "BIOLOGICAL" }, { "name": "Placebo (saline water)", "type": "BIOLOGICAL" }, { "name": "Prevnar 20", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Weeks", "maximum_age": "12 Weeks", "sex": "ALL", "summary": "6 Weeks to 12 Weeks" }, "enrollment_count": 1196, "start_date": "2018-07-27", "completion_date": "2024-12-27", "has_results": true, "last_update_posted_date": "2026-02-10", "last_synced_at": "2026-05-22T09:05:02.502Z", "location_count": 56, "location_summary": "Birmingham, Alabama • Fayetteville, Arkansas • Jonesboro, Arkansas + 47 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Oakland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03621670" } ] }